While Medicare’s proposed accountable care organization (ACO) rule doesn’t impede pathologists from actively contributing to the model’s success, one concern is that it may not enable pathologists to maximize their value within the health care system. The College outlined these and other observations in official comments to CMS on the proposed rule, submitted earlier this week.
Read full story at CAP STATLINE.
More CAP STATLINE news:
Noted Pathologist James Madara, MD, Named AMA CEO
The AMA has announced that distinguished academic pathologist, James L. Madara, MD, will take over as Executive Vice President and CEO as of July 1. The current EVP and CEO, Michael Maves, MD, will end his tenure on June 30.
Dr. Madara comes to the AMA from Leavitt Partners, where he was senior advisor at the health care consulting firm started by former Secretary of Health and Human Services Mike Leavitt. Before joining Leavitt Partners, Dr. Madara was at the University of Chicago from 2002-2009, where he served as the Thompson Distinguished Service Professor and Dean at the University of Chicago Pritzker School of Medicine, as well as the CEO of the University of Chicago Medical Center. Prior to this post, he was the Timmie Professor and Chair of Pathology and Laboratory Medicine at the Emory University School of Medicine in Atlanta.
Read full story.
